Whether we are predisposed to particular diseases depends to a large extent on the countless variants in our genome.
Quicktake – ImmunoGen Inc., (IMGN) | Biotech Investment Blog | biotickr
ImmunoGen Inc. is a clinical-stage biotechnology company focusing on the development of antibody-drug conjugate (ADC) as a treatment for cancer. The lead pipeline is mirvetuximab